Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleClinical Investigations

Comparison Between 18F-FDG PET Image–Derived Indices for Early Prediction of Response to Neoadjuvant Chemotherapy in Breast Cancer

Mathieu Hatt, David Groheux, Antoine Martineau, Marc Espié, Elif Hindié, Sylvie Giacchetti, Anne de Roquancourt, Dimitris Visvikis and Catherine Cheze-Le Rest
Journal of Nuclear Medicine March 2013, 54 (3) 341-349; DOI: https://doi.org/10.2967/jnumed.112.108837
Mathieu Hatt
1INSERM, UMR 1101 LaTIM, Brest, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Groheux
2Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France
3B2T, Doctoral School, IUH, University of Paris VII, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Antoine Martineau
2Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marc Espié
4Breast Diseases Unit, Department of Medical Oncology, Saint-Louis Hospital, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elif Hindié
5Department of Nuclear Medicine, Haut-Lévêque Hospital, University of Bordeaux, Bordeaux, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sylvie Giacchetti
4Breast Diseases Unit, Department of Medical Oncology, Saint-Louis Hospital, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anne de Roquancourt
6Department of Pathology, Saint-Louis Hospital, Paris, France; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dimitris Visvikis
1INSERM, UMR 1101 LaTIM, Brest, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Catherine Cheze-Le Rest
1INSERM, UMR 1101 LaTIM, Brest, France
7Department of Nuclear Medicine, CHU Milétrie, Poitiers, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 54 no. 3 341-349
DOI 
https://doi.org/10.2967/jnumed.112.108837
PubMed 
23327900

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication June 12, 2012
  • Accepted for publication October 2, 2012
  • Published online March 1, 2013.

Article Versions

  • previous version (January 17, 2013 - 04:36).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2013 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Author Information

  1. Mathieu Hatt1,
  2. David Groheux2,3,
  3. Antoine Martineau2,
  4. Marc Espié4,
  5. Elif Hindié5,
  6. Sylvie Giacchetti4,
  7. Anne de Roquancourt6,
  8. Dimitris Visvikis1 and
  9. Catherine Cheze-Le Rest1,7
  1. 1INSERM, UMR 1101 LaTIM, Brest, France
  2. 2Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France
  3. 3B2T, Doctoral School, IUH, University of Paris VII, France
  4. 4Breast Diseases Unit, Department of Medical Oncology, Saint-Louis Hospital, Paris, France
  5. 5Department of Nuclear Medicine, Haut-Lévêque Hospital, University of Bordeaux, Bordeaux, France
  6. 6Department of Pathology, Saint-Louis Hospital, Paris, France; and
  7. 7Department of Nuclear Medicine, CHU Milétrie, Poitiers, France
  1. For correspondence or reprints contact: Mathieu Hatt, INSERM, UMR 1101 LaTIM, CHRU Morvan, 5 Avenue Foch, 29609 Brest, France. E-mail: hatt{at}univ-breast.fr
View Full Text

Statistics from Altmetric.com

Cited By...

  • 72 Citations
  • 72 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Current Methods to Define Metabolic Tumor Volume in Positron Emission Tomography: Which One is Better?
    Hyung-Jun Im, Tyler Bradshaw, Meiyappan Solaiyappan, Steve Y. Cho
    Nuclear Medicine and Molecular Imaging 2018 52 1
  • Robustness of intratumour 18F-FDG PET uptake heterogeneity quantification for therapy response prediction in oesophageal carcinoma
    Mathieu Hatt, Florent Tixier, Catherine Cheze Le Rest, Olivier Pradier, Dimitris Visvikis
    European Journal of Nuclear Medicine and Molecular Imaging 2013 40 11
  • Multimodality Imaging for Evaluating Response to Neoadjuvant Chemotherapy in Breast Cancer
    Gaiane M. Rauch, Beatriz Elena Adrada, Henry Mark Kuerer, Raquel F. D. van la Parra, Jessica W. T. Leung, Wei Tse Yang
    American Journal of Roentgenology 2017 208 2
  • PET/CT in Oncology: Current Status and Perspectives
    Johannes Czernin, Martin Allen-Auerbach, David Nathanson, Ken Herrmann
    Current Radiology Reports 2013 1 3
  • A Phase II Study of 3′-Deoxy-3′-18F-Fluorothymidine PET in the Assessment of Early Response of Breast Cancer to Neoadjuvant Chemotherapy: Results from ACRIN 6688
    Lale Kostakoglu, Fenghai Duan, Michael O. Idowu, Paul R. Jolles, Harry D. Bear, Mark Muzi, Jean Cormack, John P. Muzi, Daniel A. Pryma, Jennifer M. Specht, Linda Hovanessian-Larsen, John Miliziano, Sharon Mallett, Anthony F. Shields, David A. Mankoff
    Journal of Nuclear Medicine 2015 56 11
  • 18F-FDG uptake in breast cancer correlates with immunohistochemically defined subtypes
    Hye Ryoung Koo, Jeong Seon Park, Keon Wook Kang, Nariya Cho, Jung Min Chang, Min Sun Bae, Won Hwa Kim, Su Hyun Lee, Mi Young Kim, Jin You Kim, Mirinae Seo, Woo Kyung Moon
    European Radiology 2014 24 3
  • Early prediction of neoadjuvant chemotherapy response for advanced breast cancer using PET/MRI image deep learning
    Joon Ho Choi, Hyun-Ah Kim, Wook Kim, Ilhan Lim, Inki Lee, Byung Hyun Byun, Woo Chul Noh, Min-Ki Seong, Seung-Sook Lee, Byung Il Kim, Chang Woon Choi, Sang Moo Lim, Sang-Keun Woo
    Scientific Reports 2020 10 1
  • PET quantification: strategies for partial volume correction
    V. Bettinardi, I. Castiglioni, E. De Bernardi, M. C. Gilardi
    Clinical and Translational Imaging 2014 2 3
  • 18FDG-PET/CT for predicting the outcome in ER+/HER2- breast cancer patients: comparison of clinicopathological parameters and PET image-derived indices including tumor texture analysis
    David Groheux, Antoine Martineau, Luis Teixeira, Marc Espié, Patricia de Cremoux, Philippe Bertheau, Pascal Merlet, Charles Lemarignier
    Breast Cancer Research 2017 19 1
  • Correlation between tumour characteristics, SUV measurements, metabolic tumour volume, TLG and textural features assessed with 18F-FDG PET in a large cohort of oestrogen receptor-positive breast cancer patients
    Charles Lemarignier, Antoine Martineau, Luis Teixeira, Laetitia Vercellino, Marc Espié, Pascal Merlet, David Groheux
    European Journal of Nuclear Medicine and Molecular Imaging 2017 44 7

Article usage

Article usage: January 2013 to April 2025

AbstractFullPdf
Jan 2013390057
Feb 2013241053
Mar 2013192379195
Apr 20134691648
May 20133454157
Jun 20131741828
Jul 20131011419
Aug 2013116921
Sep 2013771823
Oct 2013622836
Nov 20131061520
Dec 2013541523
Jan 2014701722
Feb 2014581524
Mar 2014792524
Apr 2014812529
May 2014543018
Jun 201452714
Jul 2014351314
Aug 2014492215
Sep 2014582833
Oct 2014392623
Nov 2014301614
Dec 2014383221
Jan 2015201719
Feb 2015312510
Mar 2015441919
Apr 2015361914
May 2015371811
Jun 201512279
Jul 20151799
Aug 201519128
Sep 20154767
Oct 20152189
Nov 201528115
Dec 2015541416
Jan 2016371417
Feb 2016391719
Mar 20162257
Apr 20162769
May 201629812
Jun 201637614
Jul 201628321
Aug 201623212
Sep 201633812
Oct 20163068
Nov 201641518
Dec 201632722
Jan 20171354
Feb 20172663
Mar 2017461710
Apr 201761112
May 20172894
Jun 2017866
Jul 20172098
Aug 20172167
Sep 201713114
Oct 2017161618
Nov 20171957
Dec 20171355
Jan 20181655
Feb 20181194
Mar 20181056
Apr 20181423
May 201813104
Jun 20181413
Jul 20181901
Aug 2018621
Sep 2018743
Oct 2018623
Nov 2018801
Dec 20182045
Jan 20191064
Feb 2019703
Mar 20192076
Apr 20191714
May 20191017
Jun 20191037
Jul 20191237
Aug 20191514
Sep 2019913
Oct 201915510
Nov 20191054
Dec 20191446
Jan 20201409
Feb 20201037
Mar 202010412
Apr 2020317
May 2020417
Jun 2020817
Jul 2020703
Aug 2020111114
Sep 2020827
Oct 20201327
Nov 2020759
Dec 202015110
Jan 202161011
Feb 2021121616
Mar 202131415
Apr 20215128
May 2021112213
Jun 20215133
Jul 202181317
Aug 20215159
Sep 20213919
Oct 202141831
Nov 20214917
Dec 20214195
Jan 20228810
Feb 202242011
Mar 20222146
Apr 20222109
May 202241612
Jun 20222147
Jul 202262511
Aug 20224116
Sep 202262115
Oct 20223157
Nov 20221115
Dec 20223147
Jan 202343614
Feb 202342311
Mar 202343114
Apr 20231133
May 20235159
Jun 20230113
Jul 2023397
Aug 202311416
Sep 2023183
Oct 202322112
Nov 202341713
Dec 20236148
Jan 202417215
Feb 2024111414
Mar 202491235
Apr 202467916
May 202416911
Jun 202452414
Jul 202483013
Aug 2024122824
Sep 202463013
Oct 20243249
Nov 20248179
Dec 20240279
Jan 20250186
Feb 2025125612
Mar 202544312
Apr 202565931
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 54 (3)
Journal of Nuclear Medicine
Vol. 54, Issue 3
March 1, 2013
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Comparison Between 18F-FDG PET Image–Derived Indices for Early Prediction of Response to Neoadjuvant Chemotherapy in Breast Cancer
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Comparison Between 18F-FDG PET Image–Derived Indices for Early Prediction of Response to Neoadjuvant Chemotherapy in Breast Cancer
Mathieu Hatt, David Groheux, Antoine Martineau, Marc Espié, Elif Hindié, Sylvie Giacchetti, Anne de Roquancourt, Dimitris Visvikis, Catherine Cheze-Le Rest
Journal of Nuclear Medicine Mar 2013, 54 (3) 341-349; DOI: 10.2967/jnumed.112.108837

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Comparison Between 18F-FDG PET Image–Derived Indices for Early Prediction of Response to Neoadjuvant Chemotherapy in Breast Cancer
Mathieu Hatt, David Groheux, Antoine Martineau, Marc Espié, Elif Hindié, Sylvie Giacchetti, Anne de Roquancourt, Dimitris Visvikis, Catherine Cheze-Le Rest
Journal of Nuclear Medicine Mar 2013, 54 (3) 341-349; DOI: 10.2967/jnumed.112.108837
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Repeatability of Quantitative Whole-Body 18F-FDG PET/CT Uptake Measures as Function of Uptake Interval and Lesion Selection in Non-Small Cell Lung Cancer Patients
  • Imaging Diagnostic and Therapeutic Targets: Human Epidermal Growth Factor Receptor 2
  • A Phase II Study of 3'-Deoxy-3'-18F-Fluorothymidine PET in the Assessment of Early Response of Breast Cancer to Neoadjuvant Chemotherapy: Results from ACRIN 6688
  • Multimodal Partial-Volume Correction: Application to 18F-Fluoride PET/CT Bone Metastases Studies
  • Baseline Tumor 18F-FDG Uptake and Modifications After 2 Cycles of Neoadjuvant Chemotherapy Are Prognostic of Outcome in ER+/HER2- Breast Cancer
  • Role of Positron Emission Tomography for the Monitoring of Response to Therapy in Breast Cancer
  • Google Scholar

More in this TOC Section

  • Cardiac Presynaptic Sympathetic Nervous Function Evaluated by Cardiac PET in Patients with Chronotropic Incompetence Without Heart Failure
  • Validation and Evaluation of a Vendor-Provided Head Motion Correction Algorithm on the uMI Panorama PET/CT System
  • Prognostic Role of 68Ga-PSMA11 PET–Based Response in Patients with Prostate Cancer Undergoing Taxane-Based Chemotherapy
Show more Clinical Investigations

Similar Articles

Keywords

  • breast cancer
  • neoadjuvant chemotherapy
  • 18F-FDG
  • tumor delineation
  • pathological response
SNMMI

© 2025 SNMMI

Powered by HighWire